Holen Sie sich die Stockscreener-App
16.71
3.47%
-0.60
Handel nachbörslich:
16.71
Finanzdaten der Fulgent Genetics Inc-Aktie (FLGT)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
8.54%
64.48
|
70.50 | 84.69 | 67.85 | 66.17 |
| Cost Of Revenue |
6.39%
42.38
|
45.28 | 44.84 | 47.28 | 47.36 |
| Gross Profit |
12.39%
22.10
|
25.23 | 39.84 | 20.57 | 18.81 |
Operating Expenses
|
75.11%
43.90
|
176.35 | 39.63 | 40.37 | 43.63 |
| Benefits Costs and Expenses |
63.53%
78.66
|
215.70 | 77.83 | 82.55 | 87.22 |
| Costs And Expenses |
63.53%
78.66
|
215.70 | 77.83 | 82.55 | 87.22 |
| Operating Income/Loss |
85.58%
-21.80
|
-151.12 | 0.214 | -19.80 | -24.82 |
| Income/Loss From Continuing Operations Before Tax |
90.24%
-14.17
|
-145.20 | 6.86 | -14.70 | -21.05 |
| Income Tax Expense/Benefit, Deferred |
210.96%
-0.557
|
0.502 | 19.38 | -3.218 | -5.20 |
| Income Tax Expense/Benefit |
96.99%
-0.327
|
-10.86 | 20.33 | -3.11 | -5.20 |
| Income/Loss From Continuing Operations After Tax |
89.69%
-13.85
|
-134.33 | -13.47 | -11.59 | -15.85 |
|
Net Income/Loss
|
89.69%
-13.85
|
-134.33 | -13.47 | -11.59 | -15.85 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
93.79%
-0.384
|
-6.185 | -0.359 | -0.361 | -0.509 |
| Basic Average Shares |
595.48K%
29.77
|
-0.005 | 30.01 | 29.81 | 29.54 |
| Diluted Average Shares |
595.48K%
29.77
|
-0.005 | 30.01 | 29.81 | 29.54 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
5.04%
3.19%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):